Labs

Major Legal Victory: Zest Labs Secures $72.7 Million Verdict Against Walmart in High-Stakes Trade Secrets Case

by

LITTLE ROCK, Ark. — Zest Labs, Inc. has emerged victorious in a landmark legal battle against Walmart, receiving one of the largest verdicts in Arkansas history following a dispute over trade secrets. A federal jury awarded Zest $72.7 million in compensatory damages and $150 in punitive damages against the retail giant. The lawsuit, initiated in 2018, stemmed from allegations that Walmart misappropriated Zest’s proprietary supply chain technology. Zest’s Fresh Solution was developed to minimize food waste by leveraging data to forecast the expiration of perishable goods as they moved through the supply chain. By utilizing … Read more

Deadline Approaches for BioAge Labs Investors to Join Securities Fraud Lawsuit Following Failed Clinical Trial

by

SAN DIEGO — Robbins Geller Rudman & Dowd LLP, a prominent law firm, has issued an announcement regarding a class action lawsuit against BioAge Labs, Inc., urging investors to come forward if they were affected by the company’s recent IPO issues. Shareholders who acquired stock in BioAge Labs (NASDAQ: BIOA) during its initial public offering on September 26, 2024, or based on the related registration statement, are invited to seek a lead plaintiff position in the lawsuit by the impending deadline of March 10, 2025. The lawsuit, officially known as Soto v. BioAge Labs, Inc., … Read more

Bleichmar Fonti & Auld LLP Files Lawsuit Against BioAge Labs Over Alleged IPO Misrepresentations, Urges Investors to Join Legal Action

by

NEW YORK — Legal actions have commenced against BioAge Labs, Inc., a clinical-stage biopharmaceutical company known for its advanced therapies aimed at metabolic diseases like obesity. A lawsuit filed in the U.S. District Court for the Northern District of California accuses BioAge and some of its top executives of potential breaches of federal securities laws. The securities law firm Bleichmar Fonti & Auld LLP, leading the litigations, announced these proceedings detailing that the lawsuit encapsulates claims under Sections 11 and 15 of the Securities Act of 1933. The complaint specifically represents investors who acquired shares … Read more

Nova Labs Inc. Under SEC Scrutiny for Alleged Unregistered Crypto Asset Sales

by

Nova Labs Inc., a prominent technology company, is currently under scrutiny by the U.S. Securities and Exchange Commission (SEC). The allegations suggest that the company may have breached federal securities laws through its distribution of “hotspot” crypto asset mining devices, which are said to be unregistered investment contracts. This controversy touches on broader issues within the rapidly evolving cryptocurrency mining industry, where regulatory frameworks struggle to keep pace with technological advancements. According to the SEC, Nova Labs Inc. implemented a strategy aimed at circumventing established securities laws, thereby raising questions about the legalities of crypto … Read more